Adding to this, does anyone think we should be going for mTNBC instead of NASH first? I don't know what a phase 3 mTNBC trial costs but the average cost of a phase 3 NASH trial is around $20m according to the Department of Health and Human Service. NASH seems like an indication where people are getting through to Phase 3 and that's ultimately where they fail but our results on mTNBC were fantastic and we have fast track designation for that indication. Seems like that would be the easiest path to revenue and then we go do NASH.